🇺🇸 FDA
Pipeline program

Vir-3434, Vir-2218, Pegasys 180 micrograms solution for injection in pre-filled syringe

VIR-2218-1006

Phase 2 small_molecule active

Quick answer

Vir-3434, Vir-2218, Pegasys 180 micrograms solution for injection in pre-filled syringe for Chronic Hepatitis B Virus Infection is a Phase 2 program (small_molecule) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Vir Biotechnology
Indication
Chronic Hepatitis B Virus Infection
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials